2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine manufacturers
|
| | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine Basic information |
| Product Name: | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine | | Synonyms: | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine;2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-fluorouridine;2’,3’,5’-Tri-O-benzoyl-2’-C-methyl-5-fluorouridine;2’,3’,5’-Tri-O-benzoyl-2’-C-methyl-5-fluorouriddine;(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-4-methyloxolan-2-yl]methylbenzoate | | CAS: | 2072145-49-2 | | MF: | C31H25FN2O9 | | MW: | 588.54 | | EINECS: | | | Product Categories: | | | Mol File: | 2072145-49-2.mol |  |
| | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | pka | 7.63±0.10(Predicted) |
| | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine Usage And Synthesis |
| Uses | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-fluorouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-fluorouridine Preparation Products And Raw materials |
|